Nicholas Arpaia

26PUBLICATIONS
81CO-AUTHORS
Microbial taxonomyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBiomaterialsRehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 30, 2026
A genome‑wide screen in E. coli reveals metabolic adaptations that enhance intratumoral fitness and bacterial cancer therapy efficacy.

|Sep 16, 2026
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.

|Aug 11, 2026
A novel CAF population coordinates hyper-suppressive regulatory T cell recruitment and localization in lung cancer.

|Jul 22, 2026
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models.

|Jun 04, 2026
Bacterial engineering for cancer therapy.

|May 27, 2026
Temperate phages enhance bacterial host fitness via RNA-guided flagellar remodelling.

Pageof 5

Frequent Collaborators

12 joint publications

Tal Danino

6 joint publications

Thomas Savage

6 joint publications

Kenia de Los Santos-Alexis

6 joint publications

Jongwon Im